J. Mar

发表

[Probabilistic Markov models in economic evaluation of health technologies: a practical guide].

Javier Mar, Arantzazu Arrospide, Fernando Antoñanzas, 2010, Gaceta sanitaria.

Cost-Effectiveness Analysis of Thrombolytic Treatment for Stroke

J. Mar, J. Begiristáin, A. Arrazola, 2005, Cerebrovascular Diseases.

Cost-effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously non-responders to interferon

J. Mar, J. C. Hita, R. Miguel, 2003 .

Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?

J. Mar, F. Rodríguez‐Artalejo, 2001, Journal of hypertension.

Modeling Using Discrete Event Simulation

J. Caro, A. Brennan, J. Mar, 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model.

Javier Mar, Arantzazu Arrospide, Mercè Comas, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Incorporating Budget Impact Analysis in the Implementation of Complex Interventions: A Case of an Integrated Intervention for Multimorbid Patients within the CareWell Study.

J. Mar, A. Arrospide, M. Soto-Gordoa, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea

J. Mar, C. Schechter, J. Chilcott, 2003, European Respiratory Journal.

Reliability of portal control procedure in irradiation of breast cancer: a Bayesian analysis.

J. Mar, R. Pastor-Barriuso, A. Alía, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact Assessment of an Innovative Integrated Care Model for Older Complex Patients with Multimorbidity: The CareWell Project

J. Mar, V. Stroetmann, Reinhard Hammerschmidt, 2020, International journal of integrated care.

Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease.

J. Molinuevo, J. Mar, L. Perestelo-Pérez, 2014, Journal of Alzheimer's disease : JAD.

Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia

J. Mar, A. Arrospide, P. Martínez-Lage, 2015, Alzheimer's Research & Therapy.

Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model

H. D. de Koning, J. Mar, A. Arrospide, 2017, BMC Public Health.

Plasma lipids are associated with white matter microstructural changes and axonal degeneration

J. Mar, A. Arrospide, F. Goñi, 2020, Brain Imaging and Behavior.

Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model

H. D. de Koning, J. Mar, A. Arrospide, 2018, BMC Cancer.

Cost–effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C

J. Mar, V. Gimeno-Ballester, R. San Miguel, 2016, Expert review of pharmacoeconomics & outcomes research.

The interplay between subcritical fluctuations and import: understanding COVID-19 epidemiology dynamics

J. B. Van-Dierdonck, Joseba Bidaurrazaga Van-Dierdonck, N. Stollenwerk, 2020, medRxiv.

Evaluation of the implementation of an integrated program for musculoskeletal system care.

J. Mar, A. Arrospide, M. Soto-Gordoa, 2017 .

Impact of stratification on the effectiveness of a comprehensive patient‐centered strategy for multimorbid patients

J. Mar, A. Arrospide, J. Igartua, 2018, Health services research.

Projecting Burden of Dementia in Spain, 2010-2050: Impact of Modifying Risk Factors.

J. Mar, A. Arrospide, P. Martínez-Lage, 2015, Journal of Alzheimer's disease : JAD.

[The cost of applying the Dependency Law to Alzheimer disease].

J. Mar, A. Arrospide, M. Soto-Gordoa, 2014, Gaceta sanitaria.

Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation

M. Comas, M. Rué, J. Mar, 2015, BMC Cancer.

Stage- and age-adjusted cost-effectiveness analysis of laparoscopic surgery in rectal cancer

J. Mar, A. Arrospide, M. Redondo, 2019, Surgical Endoscopy.

Risk factors affecting hospital stay among patients undergoing colon cancer surgery: a prospective cohort study

J. Mar, M. Espallargues, J. Espinàs, 2019, Supportive Care in Cancer.

Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence

J. Mar, M. Simón, V. Gimeno-Ballester, 2016, Expert review of gastroenterology & hepatology.

Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

J. Mar, R. Miguel, V. Gimeno-Ballester, 2016 .

[Cost and mortality associated to the surgical delay of patients with a hip fracture. Spain].

J. Mar, A. Arrospide, Í. Etxebarría-Foronda, 2013, Revista espanola de salud publica.

Incidence of Dementia and Associated Factors in the EPIC-Spain Dementia Cohort.

J. Mar, C. Navarro, P. Amiano, 2020, Journal of Alzheimer's disease : JAD.

Validation of machine learning models to predict dementia-related neuropsychiatric symptoms in real-world data

J. Mar, A. Arrospide, C. Cernuda, 2020 .

Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data

J. Mar, A. Arrospide, C. Cernuda, 2020, Journal of Alzheimer's disease : JAD.

[Factors associated with the prevalence of hypovitaminosis D in pregnant women and their newborns].

J. Mar, A. Arrospide, E. Blarduni, 2019, Anales de pediatria.

[Factors associated with the prevalence of hypovitaminosis D in pregnant women and their newborns].

J. Mar, A. Arrospide, E. Blarduni, 2018, Anales de pediatria.

Mediterranean Diet and Risk of Dementia and Alzheimer’s Disease in the EPIC-Spain Dementia Cohort Study

J. Mar, C. Navarro, P. Amiano, 2021, Nutrients.

Is the incidence of hip fractures becoming lower

J. Mar, Í. Etxebarría-Foronda, 2013 .

Is the incidence of hip fractures becoming lower?

J. Mar, Í. Etxebarría-Foronda, 2013, Reumatologia clinica.

Cost-effectiveness analysis of text messaging to support health advice for smoking cessation

J. Mar, F. Aizpuru, G. Orive, 2020, Cost Effectiveness and Resource Allocation.

Plasma lipids are associated with white matter microstructural changes and axonal degeneration

J. Mar, A. Arrospide, F. Goñi, 2020, Brain Imaging and Behavior.

Proposal to inform European institutions regarding the regulation of conscientious objection to abortion

Javier Mar, Oliver Ibarrondo, Sam Rowlands, 2016, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Ambulatory Blood Pressure Monitoring and Diagnostic Errors in Hypertension

J. Mar, R. Pastor, R. Abasolo, 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[A proposed guideline for economic evaluation of health technologies].

J. Mar, F. Antoñanzas, J. Puig-Junoy, 2010, Gaceta sanitaria.

Modeling Using Discrete Event Simulation

Jonathan Karnon, Alan Brennan, Javier Mar, 2012 .

Cost-Effectiveness Methods and Newborn Screening Assessment.

J. Mar, M. Couce, P. Serrano-Aguilar, 2017, Advances in experimental medicine and biology.

Cost Analysis of Real-Time Polymerase Chain Reaction Microbiological Diagnosis in Patients with Septic Shock

J. Mar, B. Regueiro, Jaime Rodríguez, 2012, Anaesthesia and intensive care.

Unmet needs for cataract surgery in Spain according to indication criteria. Evaluation through a simulation model

M. Comas, F. Cots, J. Mar, 2008, British Journal of Ophthalmology.

Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literature

J. Mar, V. Gimeno-Ballester, R. San Miguel, 2014, Expert review of pharmacoeconomics & outcomes research.

Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients

J. Mar, R. San Miguel, A. Blázquez-Pérez, 2013, PharmacoEconomics.

Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C

J. Mar, V. Gimeno-Ballester, R. San Miguel, 2014, Gut.

Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients

J. Mar, R. Adams, A. O'Leary, 2017, Expert review of gastroenterology & hepatology.

Measuring health-related quality of life in drug clinical trials: is it given due importance?

J. Mar, R. Miguel, J. Cabasés, 2008, Pharmacy World & Science.

Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test: a discrete event simulation model.

Javier Mar, Arantzazu Arrospide, Oliver Ibarrondo, 2018, Gaceta sanitaria.

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

J. Mar, A. Plazaola, O. Ibarrondo, 2018, ClinicoEconomics and outcomes research : CEOR.

Association Between Egg Consumption and Dementia Risk in the EPIC-Spain Dementia Cohort

J. Mar, M. Crous-Bou, P. Amiano, 2022, Frontiers in Nutrition.

Spanish recommendations on economic evaluation of health technologies

Anna García-Altés, Javier Mar, Fernando Antoñanzas, 2010, The European Journal of Health Economics.

Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain

J. Mar, J. Álvarez-Sabín, J. Masjuán, 2015, Health and Quality of Life Outcomes.

Economic Evaluation of an Integrated Health and Social Care Program for Heart Failure Through 2 Different Modeling Techniques

Javier Mar, Igor Larrañaga, Panos Stafylas, 2018, Health services research and managerial epidemiology.

Validation of the Spanish Translation of the Questionnaire for the Obesity-Related Problems Scale

J. Mar, A. Arrospide, A. Bilbao, 2009, Obesity Surgery.

Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population

J. Mar, A. Arrospide, J. Begiristáin, 2010, ClinicoEconomics and outcomes research : CEOR.

Impact of an organised population screening programme for colorectal cancer: Measurement after first and second rounds

J. Mar, A. Arrospide, L. Imaz, 2020, Journal of medical screening.

Changes in lung cancer survival by TNM stage in the Basque country from 2003 to 2014 according to period of diagnosis.

J. Mar, A. Arrospide, R. Clèries, 2020, Cancer epidemiology.

Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults.

K. Blennow, J. Mar, A. Arrospide, 2020, Journal of Alzheimer's disease : JAD.

Dynamic evaluation of the comparative effectiveness of an integrated program for heart failure care.

J. Mar, A. Arrospide, O. Ibarrondo, 2020, Journal of evaluation in clinical practice.

Economic impact of patients admitted to stroke units in Spain

Javier Mar, Juan Oliva-Moreno, J. Mar, 2017, The European Journal of Health Economics.

The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life

J. Mar, A. Arrospide, J. Begiristáin, 2011, BMC neurology.

[The availability in Spanish public hospitals of resources for diagnosing and treating sleep apnea-hypopnea syndrome].

J. Mar, J. Durán-Cantolla, R. Rubio Aramendi, 2004, Archivos de bronconeumologia.

Cost–Utility Analysis of Gastric Bypass for Severely Obese Patients in Spain

J. Mar, A. Arrospide, C. Valcárcel-Nazco, 2014, Obesity Surgery.

Determinants of Informal Care, Burden, and Risk of Burnout in Caregivers of Stroke Survivors: The CONOCES Study

J. Mar, J. Álvarez-Sabín, J. Masjuán, 2018, Stroke.

Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity

J. Mar, A. Arrospide, Iván Castilla, 2021, Medical decision making : an international journal of the Society for Medical Decision Making.

Economic evaluation of a population strategy for the treatment of chronic hepatitis C with direct-acting antivirals.

J. Mar, A. Arrospide, J. Castilla, 2018, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.

Jonathan Karnon, James Stahl, Alan Brennan, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis

M. Comas, M. Rué, J. Mar, 2016, BMC Cancer.

Discrete-event simulation applied to analysis of waiting lists. Evaluation of a prioritization system for cataract surgery.

Javier Mar, Mercè Comas, Mireia Espallargues, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer

J. Mar, A. Arrospide, M. Redondo, 2018, Surgical Endoscopy.

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain

M. Rué, J. Mar, A. Arrospide, 2013, BMC Cancer.

Estimation of the epidemiology of dementia and associated neuropsychiatric symptoms by applying machine learning to real-world data

J. Mar, A. Arrospide, C. Cernuda, 2021, Revista de psiquiatria y salud mental.

Gender and socioeconomic inequalities in the implementation of the Basque programme for multimorbid patients.

J. Mar, A. Arrospide, J. Igartua, 2019, European journal of public health.

J. Mar, A. Arrospide, M. Tainta, 2019, Neuropsychiatric disease and treatment.

The cost of colorectal cancer according to the TNM stage

J. Mar, A. Arrospide, J. Errasti, 2017 .

Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012)

J. Mar, A. Arrospide, J. Caeiro, 2015, Osteoporosis International.

Trends in the incidence of hip fractures in women in the Basque country

J. Mar, A. Arrospide, Í. Etxebarría-Foronda, 2010 .

Role of health-related quality of life measurements in the design of drug clinical trials.

J. Mar, R. Miguel, M. D. Frutos, 2010, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Advanced prostate cancer survival in Spain according to the Gleason score, age and stage.

J. Mar, A. Arrospide, J. Extramiana, 2016 .

Two-year changes in generic and obesity-specific quality of life after gastric bypass

J. Mar, A. Arrospide, J. Karlsson, 2013, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

Modelling COVID 19 in the Basque Country from introduction to control measure response

M. Aguiar, J. B. Van-Dierdonck, J. Mar, 2020, Scientific Reports.

Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

J. Mar, A. Arrospide, P. Martínez-Lage, 2020, Alzheimer's research & therapy.

[The cost of cerebrovascular accident].

J. Mar, A. Arrazola, J. M. Beguiristain, 2005, Revista de neurologia.

Budget Impact Analysis of Switching to Digital Mammography in a Population-Based Breast Cancer Screening Program: A Discrete Event Simulation Model

X. Castells, M. Comas, F. Cots, 2014, PLoS ONE.

Cost‐effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon

J. Mar, M. Buti, F. Guillén-Grima, 2003, Alimentary Pharmacology and Therapeutics.

[Cost-analysis of viscosupplementation treatment with hyaluronic acid in candidate knee replacement patients with osteoarhritis].

J. Mar, A. Arrospide, B. Soler López, 2013, Revista espanola de cirugia ortopedica y traumatologia.

Geographical variations in the benefit of applying a prioritization system for cataract surgery in different regions of Spain

Javier Mar, Mercè Comas, Xavier Castells, 2008, BMC health services research.

Outcomes of open versus laparoscopic surgery in patients with colon cancer.

J. Mar, M. Espallargues, J. Espinàs, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Mathematical models for economic evaluation: dynamic models based on differential equations].

Javier Mar, Roberto Pradas Velasco, Fernando Antoñanzas Villar, 2009, Gaceta sanitaria.

Practices Task Force Modeling Using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research

Jonathan Karnon, Alan Brennan, Javier Mar, 2014 .

Calculation of Prevalence with Markov Models: Budget Impact Analysis of Thrombolysis for Stroke

J. Mar, Erika Miranda-Serrano, María Sainz-Ezkerra, 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

The costs of stroke in Spain by aetiology: the CONOCES study protocol.

J. Mar, J. Arenillas, J. Álvarez-Sabín, 2013, Neurologia.

Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

Iván Castilla-Rodríguez, Javier Mar, Pedro Serrano-Aguilar, 2016 .

Validity of a computerised population registry of dementia based on clinical databases.

J. Mar, A. Arrospide, P. Martínez-Lage, 2020, Neurologia.

Minimum intravenous thrombolysis utilization rates in acute ischemic stroke to achieve population effects on disability: A discrete-event simulation model

X. Castells, M. Comas, J. Mar, 2016, Journal of the Neurological Sciences.

Critical fluctuations in epidemic models explain COVID-19 post-lockdown dynamics

Joseba Bidaurrazaga Van-Dierdonck, N. Stollenwerk, J. Mar, 2021, Scientific Reports.

Survival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments

J. Mar, J. Castilla, I. Martínez-Baz, 2019, Expert review of gastroenterology & hepatology.